Clinical Trial Update: Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence [Phase 4]

View source ↗

Summary

Phase 4 trial updating on a beta-adrenergic agonist versus OnabotulinumtoxinA for urgency urinary incontinence, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Incontinence

Drugs mentioned

• Mirabegron (mirabegron)
• OnabotulinumtoxinA (Botox) (Botulinum toxin type A)

Snippet

Sponsor: Women and Infants Hospital of Rhode Island | Conditions: Urgency Urinary Incontinence | Phase 4 | Status: RECRUITING